Immune infiltration analysis based on pyroptosis-related gene in metabolic dysfunction-associated fatty liver disease

被引:0
|
作者
Lian, Xin [1 ]
Tang, Xulei [1 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China
关键词
Metabolic dysfunction-associated fatty liver; disease; Pyroptosis-related gene; Immune infiltration; Bioinformatics; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; PROTEIN; PATHOPHYSIOLOGY; INFLAMMASOMES; HEPATOCYTES; PROGRESSION; ACTIVATION; MECHANISMS; SIGNATURES;
D O I
10.1016/j.heliyon.2024.e34348
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent chronic disease that can involve pyroptosis. The primary objective of this study was to conduct a thorough and comprehensive analysis the pyroptosis-related genes in MAFLD. Methods: We identified pyroptosis-related differentially expressed genes (PRDEGs) in both healthy individuals and MAFLD patients. Using various bioinformatic approaches, we conducted an immune infiltration analysis from multiple perspectives. Results: A total of 20 pyroptosis-related LASSO genes were obtained, and 10 hub genes were used to do immune infiltration analysis. The hub genes were utilized in the construction of interaction networks between mRNA-miRNA and mRNA-TF. Immune characteristics analysis revealed multiple immune cell types significantly related to PRDEG expression, particularly genes HSP90AA1, TSLP, CDK9, and BRD4. Conclusion: Pyroptosis-related immune infiltration might be a mechanism of MAFLD progression and offers a research direction for potential treatment techniques.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Use of a ferroptosis-related gene signature to construct diagnostic and prognostic models for assessing immune infiltration in metabolic dysfunction-associated fatty liver disease
    Lian, Xin
    Tang, Xulei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [2] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [3] The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic Cancer
    Xie, Wen
    Li, Xiaoyi
    Yang, Chunxiu
    Li, Jiahao
    Shen, Guoyan
    Chen, Hongshan
    Xiao, Shu-Yuan
    Li, Yueying
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [4] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [5] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [6] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [8] Associations of depression score with metabolic dysfunction-associated fatty liver disease and liver fibrosis
    Cai, Hongwei
    Zhang, Rui
    Zhao, Chuanhao
    Wang, Yuzhuo
    Tu, Xiaoming
    Duan, Weiwei
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 334 : 332 - 336
  • [9] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi, Yiwen
    Fan, Jiangao
    CHINESE MEDICAL JOURNAL, 2022, 135 (09) : 1009 - 1018
  • [10] Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Zhao, Shuangshuang
    Guo, Yan
    Yin, Xunzhe
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (01):